Another week, another reason to preach about how the financial sector is a place investors should stay away from. Whether these companies specialize in financial planning, private banking or investment banking is irrelevant. As I’ve said before, I believe it is still too early to have faith in this particular sector. So, like last month, if you have  any of these eight financial stocks in your portfolio, I recommend figuring out how to make so that they don’t cause you any further damage.

I watch more than 5,000 publicly traded companies with my Portfolio Grader tool, ranking companies by a number of fundamental and quantitative measures. Here they are, in alphabetical order. Each one of these stocks gets a “D” or “F” according to my research, meaning it is a “sell” or “strong sell.”

Ameriprise Financial (NYSE:AMP) provides financial planning, as well as related products and services. In the past 12 months, AMP stock is down nearly 14%. AMP stock gets a “D” for sales growth, a “D” for earnings growth, a “D” for earnings momentum, a “D” for its ability to exceed the consensus earnings estimates on Wall Street and a “D” for the magnitude in which earnings projections have increased over the past month in my Portfolio Grader tool. For more information, view my complete analysis of AMP stock.

Bank of New York Mellon (NYSE:BK) is a global financial services company, based in New York, as its name suggests. BK has dipped 34% in the last year, while the Dow Jones has posted a gain of 4% in the same time frame. BK stock gets a “D” for the magnitude in which earnings projections have increased over the past month in my Portfolio Grader tool. For more information, view my complete analysis of BK stock.

Charles Schwab (NYSE:SCHW) is a savings and loan holding company that has watched its stock dip almost 36% since last February. SCHW stock gets a “D” for earnings momentum, a “D” for its ability to exceed the consensus earnings estimates on Wall Street, an “F” for the magnitude in which earnings projections have increased over the past month in my Portfolio Grader tool. For more information, view my complete analysis of SCHW stock.

Credit Suisse Group (NYSE:CS) is involved with private banking, investment banking and asset management. CS stock is down 40% in the last year, compared to gains by the broader markets. CS stock gets an “F” for sales growth, a “D” for operating margin growth, a “D” for earnings growth, an “F” for earnings momentum, an “F” for the magnitude in which earnings projections have increased over the past month and a “D” for return on equity in my Portfolio Grader tool. For more information, view my complete analysis of CS stock.

Deutsche Bank (NYSE:DB) is a global investment bank that has posted a loss of 31% in the last year. DB stock gets an “F” for sales growth, an “F” for its ability to exceed the consensus earnings estimates on Wall Street and an “F” for the magnitude in which earnings projections have increased over the past month in my Portfolio Grader tool. For more information, view my complete analysis of DB stock.

Goldman Sachs Group (NYSE:GS) is a global investment banking, securities and investment management company. In the last year, GS stock has declined 31%. GS stock gets an “F” for sales growth, a “D” for operating margin growth, an “F” for earnings growth, a “D” for earnings momentum, an “F” for the magnitude in which earnings projections have increased over the past month and a “D” for return on equity in my Portfolio Grader tool. For more information, view my complete analysis of GS stock.

T. Rowe Price Group (NASDAQ:TROW) provides investment advisory services to individual and institutional investors. A drop of 13% in the past year has TROW shareholders questioning their purchase. TROW stock gets a “D” for sales growth in my Portfolio Grader tool. For more information, view my complete analysis of TROW stock.

UBS (NYSE:UBS) is an international company known for providing wealth management, asset management and investment banking services to its clients. UBS rounds out the list with a yearly loss of 26%. UBS stock gets an “F” for sales growth, a “D” for operating margin growth, a “D” for earnings growth, a “D” for earnings momentum, an “F” for its ability to exceed the consensus earnings estimates on Wall Street and an “F” for the magnitude in which earnings projections have increased over the past month in my Portfolio Grader tool. For more information, view my complete analysis of UBS stock.

Get more analysis of these picks and other publicly traded stocks with Louis Navellier’s Portfolio Grader tool, a 100% free stock rating tool that measures both quantitative buying pressure and eight fundamental factors.